Market Overview

Structural Heart Device Market is Expected to Grow at a Medium Double-Digit CAGR to Reach $15.67 Billion by 2024 - ResearchAndMarkets.com

Share:

The "Structural
Heart Devices Global Market - Forecast to 2024"
report has been
added to ResearchAndMarkets.com's offering.

Structural heart devices by product are segmented into Repair devices
and Replacement devices. The replacement devices segment held the
largest market revenue in 2017 and expected to grow at a medium double
digit CAGR from 2017 to 2024.

In structural heart repair devices segment, transcatheter repair device
held the largest share in 2017 and is projected to grow at a strong
double digit CAGR from 2017 to 2024.

Among transcatheter repair devices, Transcatheter mitral valve repair
device held the largest share in 2017 and is projected to grow at a
strong double digit CAGR from 2017 to 2024.

The Structural heart Replacement segment is dominated by Transcatheter
valve replacement that held largest share in 2017 and expected to grow
at a strong double digit CAGR from 2017 to 2024.

Among the Surgical valve replacement devices, Tissue valves held the
largest share in 2017 and is expected to grow at a single digit CAGR
from 2017 to 2024.

Among the Transcatheter valve replacement devices, Transcatheter Aortic
Valve Replacement (TAVR) devices held the largest share and expected to
grow at a medium double digit CAGR from 2017 to 2024 and Transcatheter
Mitral Valve Replacement (TMVR) devices is expected to grow at a strong
double digit CAGR from 2017 to 2024.

North America region held the largest share in 2017 and is expected to
grow at a medium double digit CAGR from 2017 to 2024. Among North
America countries, U.S. held the largest share in 2017 and is expected
to grow at a medium double digit CAGR from 2017 to 2024.

Europe held the second largest share and is expected to grow at a medium
double digit CAGR from 2017 to 2024. Among European countries, Germany
held the largest share in 2017 and is expected to grow at a medium
double digit CAGR from 2017 to 2024.

Asia-Pacific is expected to grow at a strong double digit CAGR from 2017
to 2024. Among APAC countries, Japan held the highest share in 2017 and
is expected to grow at a strong double digit CAGR from 2017 to 2024.

RoW is expected to grow at a medium double digit CAGR from 2017 to 2024.
Among RoW countries, Brazil held the largest share in 2017 and is
expected to grow at a medium double digit CAGR from 2017 to 2024.

Companies Featured

  • Abbott Laboratories
  • Atricure
  • Balton Sp. z o.o.
  • Bard Peripheral Vascular, Inc.
  • BioVentrix, Inc.
  • BOSTON Scientific
  • Claret Medical
  • Colibri Heart Valve, LLC
  • Comed BV
  • Cook medicals LLC
  • Cryo life, Inc.
  • Edward Lifesciences
  • InterValve, Inc.
  • JC Medicals
  • JenaValve Technology GmbH
  • Leman Cardiovascular
  • LivaNova PLC
  • Mardil Medicals
  • Medtentia International Ltd Oy
  • Medtronic PLC
  • Mitralign
  • MitrAssist
  • Neochord
  • Novostia SA
  • NuMED, Inc.
  • NVT Med AG
  • Occlutech
  • Thubrikar Aortic Valve, Inc.
  • Toray Industries, Inc.
  • TransCardiac Therapeutics, LLC
  • TTKChitra HeartValve
  • Valcare Medical
  • W. L. Gore and Associates
  • Xuzhou Yatai Scientific Co. Ltd.
  • and many more...

Key Topics Covered

1 Executive Summary

2 Introduction

3 Market Analysis

4 Structural Heart Devices Global Market, by Product

5 Regional Analysis

6 Competitive Landscape

7 Major Companies

For more information about this report visit https://www.researchandmarkets.com/research/mqphhk/structural_heart?w=4

View Comments and Join the Discussion!